5-Amino-1MQ — NNMT Inhibitor and NAD+ Metabolism Regulation

Introduction

5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in NAD+ metabolism and adipose tissue regulation.

Preclinical data suggests that NNMT inhibition may improve metabolic flexibility and reduce fat accumulation by preserving intracellular NAD+ pools. The strongest evidence so far comes from animal and cell models, so this should be read as a research review, not a clinical recommendation.

Mechanism of Action

5-Amino-1MQ works by selectively inhibiting the NNMT enzyme, which leads to:

• Increased NAD+ availability
• Improved cellular energy metabolism
• Enhanced mitochondrial function

Research Applications

Current research focuses on:

• Metabolic disorders
• Obesity management
• Cardiovascular health
• Aging and longevity

In murine obesity models, NNMT inhibition was associated with lower adipose mass and improved metabolic signaling. The main hypothesis is straightforward: when NNMT activity drops, cells waste less nicotinamide on methylation and retain more substrate for NAD+-dependent energy pathways.

Safety Profile

Human evidence remains limited. The mechanistic rationale is strong, but 5-Amino-1MQ is still best understood as an experimental metabolic compound rather than a validated therapeutic option.

Conclusion

5-Amino-1MQ is one of the more interesting NNMT-targeting compounds in the current longevity and obesity research landscape. Its appeal comes from a clean mechanistic story, but translation from preclinical promise to real-world human outcomes is still an open question.